Loss of the Y chromosome linked to smoking, cancer, and higher mortality in men
the ONA take:
Researchers at Uppsala University demonstrate an association between smoking and loss of the Y chromosome in blood cells in their recent study.
In a previous study, these researchers linked loss of the Y chromosome to cancer. Combining these results could explain why men have a greater risk for smoking-related cancers and, in a broader context, an overall shorter life expectancy.
Smoking is a known risk factor for many diseases; in this study, the researchers discovered a link between smoking and genetic damage, such as loss of the Y chromosome. As only men have a Y chromosome, this might explain the sex difference in this risk, including a higher risk for cancers outside the respiratory tract in male smokers.
Two additional points revealed in the study are this association is dose dependent, ie, loss of the Y chromosome is more common in heavy smokers; and the association is valid only current smokers.
The frequency of cells with loss of the Y chromosome was found to be the same in men who were previously smokers but quit and men who never smoked.
Association between smoking and loss of the Y chromosome in blood cells in their recent study.
Sign Up for Free e-newsletters
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
- Novel Approach Can Improve Both Colorectal Cancer Screening Outcomes and Adherence
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|